170 related articles for article (PubMed ID: 15130503)
21. Immunotherapy with agonistic anti-CD137: two sides of a coin.
Sun Y; Chen JH; Fu Y
Cell Mol Immunol; 2004 Feb; 1(1):31-6. PubMed ID: 16212918
[TBL] [Abstract][Full Text] [Related]
22. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
[TBL] [Abstract][Full Text] [Related]
23. Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology.
Nolte MA; van Olffen RW; van Gisbergen KP; van Lier RA
Immunol Rev; 2009 May; 229(1):216-31. PubMed ID: 19426224
[TBL] [Abstract][Full Text] [Related]
24. Control of lymphocyte function through CD27-CD70 interactions.
Lens SM; Tesselaar K; van Oers MH; van Lier RA
Semin Immunol; 1998 Dec; 10(6):491-9. PubMed ID: 9826582
[TBL] [Abstract][Full Text] [Related]
25. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand.
Saoulli K; Lee SY; Cannons JL; Yeh WC; Santana A; Goldstein MD; Bangia N; DeBenedette MA; Mak TW; Choi Y; Watts TH
J Exp Med; 1998 Jun; 187(11):1849-62. PubMed ID: 9607925
[TBL] [Abstract][Full Text] [Related]
26. 4-1BB promotes long-term survival in skin allografts treated with anti-CD45RB and anti-CD40L monoclonal antibodies.
Lee J; Lee EN; Kim EY; Lee HJ; Park HJ; Sun CL; Lee SK; Joh JW; Lee KW; Kwon GY; Kim SJ
Transplant Proc; 2005; 37(1):123-5. PubMed ID: 15808569
[TBL] [Abstract][Full Text] [Related]
27. [Lymphocyte coreceptors].
Olive D
Med Sci (Paris); 2006 Dec; 22(12):1069-74. PubMed ID: 17156728
[TBL] [Abstract][Full Text] [Related]
28. Functional hierarchy and relative contribution of the CD28/B7 and ICOS/B7-H2 costimulatory pathways to T cell-mediated delayed-type hypersensitivity.
Wong SC; Tan AH; Lam KP
Cell Immunol; 2009; 256(1-2):64-71. PubMed ID: 19249753
[TBL] [Abstract][Full Text] [Related]
29. Virus-induced polyclonal B cell activation improves protective CTL memory via retained CD27 expression on memory CTL.
Matter M; Mumprecht S; Pinschewer DD; Pavelic V; Yagita H; Krautwald S; Borst J; Ochsenbein AF
Eur J Immunol; 2005 Nov; 35(11):3229-39. PubMed ID: 16231287
[TBL] [Abstract][Full Text] [Related]
30. Glioblastomas induce T-lymphocyte death by two distinct pathways involving gangliosides and CD70.
Chahlavi A; Rayman P; Richmond AL; Biswas K; Zhang R; Vogelbaum M; Tannenbaum C; Barnett G; Finke JH
Cancer Res; 2005 Jun; 65(12):5428-38. PubMed ID: 15958592
[TBL] [Abstract][Full Text] [Related]
31. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
32. Signalling via CD70, a member of the TNF family, regulates T cell functions.
García P; De Heredia AB; Bellón T; Carpio E; Llano M; Caparrós E; Aparicio P; López-Botet M
J Leukoc Biol; 2004 Jul; 76(1):263-70. PubMed ID: 15226368
[TBL] [Abstract][Full Text] [Related]
33. Blockade of B7-H1 with sPD-1 improves immunity against murine hepatocarcinoma.
He L; Zhang G; He Y; Zhu H; Zhang H; Feng Z
Anticancer Res; 2005; 25(5):3309-13. PubMed ID: 16101143
[TBL] [Abstract][Full Text] [Related]
34. GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily.
Nocentini G; Riccardi C
Eur J Immunol; 2005 Apr; 35(4):1016-22. PubMed ID: 15770698
[TBL] [Abstract][Full Text] [Related]
35. Anti-CD137 monoclonal antibody administration augments the antitumor efficacy of dendritic cell-based vaccines.
Ito F; Li Q; Shreiner AB; Okuyama R; Jure-Kunkel MN; Teitz-Tennenbaum S; Chang AE
Cancer Res; 2004 Nov; 64(22):8411-9. PubMed ID: 15548712
[TBL] [Abstract][Full Text] [Related]
36. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.
Gonzalez LC; Loyet KM; Calemine-Fenaux J; Chauhan V; Wranik B; Ouyang W; Eaton DL
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1116-21. PubMed ID: 15647361
[TBL] [Abstract][Full Text] [Related]
37. The contextual role of TNFR family members in CD8(+) T-cell control of viral infections.
Wortzman ME; Clouthier DL; McPherson AJ; Lin GH; Watts TH
Immunol Rev; 2013 Sep; 255(1):125-48. PubMed ID: 23947352
[TBL] [Abstract][Full Text] [Related]
38. Gene therapy using adenoviral vector encoding 4-1BBIg gene significantly prolonged murine cardiac allograft survival.
Huang BJ; Yin H; Huang YF; Xu JF; Xiong P; Feng W; Zheng F; Xu Y; Fang M; Gong FL
Transpl Immunol; 2006 Aug; 16(2):88-94. PubMed ID: 16860710
[TBL] [Abstract][Full Text] [Related]
39. Anti-CD137 monoclonal antibody promotes the direct anti-tumor effect mediated by peripheral blood-derived human dendritic cells in vitro.
Zhang L; Wang Q; Wang X; Ding P; Song J; Ma C; Sun W
Cell Mol Immunol; 2004 Feb; 1(1):71-6. PubMed ID: 16212924
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus.
Arribillaga L; Sarobe P; Arina A; Gorraiz M; Borrás-Cuesta F; Ruiz J; Prieto J; Chen L; Melero I; Lasarte JJ
Vaccine; 2005 May; 23(27):3493-9. PubMed ID: 15855007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
